These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 3490912)
21. Immunohistochemical analysis of GCDFP-15 and GCDFP-24 in mammary and non-mammary tissue. Satoh F; Umemura S; Osamura RY Breast Cancer; 2000 Jan; 7(1):49-55. PubMed ID: 11029771 [TBL] [Abstract][Full Text] [Related]
22. Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Mazoujian G; Pinkus GS; Davis S; Haagensen DE Am J Pathol; 1983 Feb; 110(2):105-12. PubMed ID: 6130702 [TBL] [Abstract][Full Text] [Related]
23. Breast gross cystic disease protein 15 in human breast cancer in culture. Miller WR; Shivas AA; Franchimont P; Haagensen DE Eur J Cancer Clin Oncol; 1988 Feb; 24(2):223-8. PubMed ID: 3356211 [TBL] [Abstract][Full Text] [Related]
24. Assay of GCDFP-15 by ELISA: an available method for in vitro studies of functional differentiation in human breast cancer. Revillion-Carette F; Hornez L; Vandewalle B; Lefebvre J Tumori; 1988 Dec; 74(6):669-74. PubMed ID: 3232212 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical study with antibody to glycoprotein GCDFP-15 for metastatic lung cancer from breast cancer. Nonami Y; Hisa S; Yamamoto A; Sasaguri S; Kiyoku H; Kurumaya H J Cardiovasc Surg (Torino); 2001 Aug; 42(4):561-4. PubMed ID: 11455297 [TBL] [Abstract][Full Text] [Related]
26. A 17-kDa CD4-binding glycoprotein present in human seminal plasma and in breast tumor cells. Autiero M; Cammarota G; Friedlein A; Zulauf M; Chiappetta G; Dragone V; Guardiola J Eur J Immunol; 1995 May; 25(5):1461-4. PubMed ID: 7774651 [TBL] [Abstract][Full Text] [Related]
27. Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. Ormsby AH; Snow JL; Su WP; Goellner JR J Am Acad Dermatol; 1995 May; 32(5 Pt 1):711-6. PubMed ID: 7722013 [TBL] [Abstract][Full Text] [Related]
28. Secretion of breast gross cystic disease fluid proteins by T47D breast cancer cells in culture--modulation by steroid hormones. Haagensen DE; Stewart P; Dilley WG; Wells SA Breast Cancer Res Treat; 1992; 23(1-2):77-86. PubMed ID: 1446056 [TBL] [Abstract][Full Text] [Related]
29. Gross cystic disease fluid protein in nipple aspirates of breast fluid of Asian and non-Asian women. Petrakis NL; Lowenstein JM; Wiencke JK; Lee MM; Wrensch MR; King EB; Hilton JF; Miike R Cancer Epidemiol Biomarkers Prev; 1993; 2(6):573-9. PubMed ID: 8268776 [TBL] [Abstract][Full Text] [Related]
31. Signet ring cells in breast carcinoma. An immunohistochemical and ultrastructural study. Yoshida A; Hatanaka S; Oneda S; Yoshida H Acta Pathol Jpn; 1992 Jul; 42(7):523-8. PubMed ID: 1329435 [TBL] [Abstract][Full Text] [Related]
32. Gross cystic disease fluid protein-15 reactivity in extramammary Paget's disease with and without associated internal malignancy. Kohler S; Smoller BR Am J Dermatopathol; 1996 Apr; 18(2):118-23. PubMed ID: 8739985 [TBL] [Abstract][Full Text] [Related]
33. Biochemical correlates of morphologic differentiation in human breast cancer. Silva JS; Cox CE; Wells SA; Paull D; Dilley WG; McCarty KS; Fetter BF; Glaubitz LC; McCarty KS Surgery; 1982 Sep; 92(3):443-9. PubMed ID: 7202259 [TBL] [Abstract][Full Text] [Related]
34. Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Bundred NJ; Stewart HJ; Shaw DA; Forrest AP; Miller WR Eur J Cancer; 1990; 26(11-12):1145-7. PubMed ID: 2149996 [TBL] [Abstract][Full Text] [Related]
35. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer. Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114 [TBL] [Abstract][Full Text] [Related]
36. Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Monteagudo C; Merino MJ; LaPorte N; Neumann RD Hum Pathol; 1991 Apr; 22(4):368-72. PubMed ID: 2050370 [TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of estrogens on GCDFP-15 mRNA levels and secretion in ZR-75-1 human breast cancer cells. Simard J; Hatton AC; Labrie C; Dauvois S; Zhao HF; Haagensen DE; Labrie F Mol Endocrinol; 1989 Apr; 3(4):694-702. PubMed ID: 2725533 [TBL] [Abstract][Full Text] [Related]
39. Potent stimulatory effect of interleukin-1 alpha on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells. Blais Y; Sugimoto K; Carriere MC; Haagensen DE; Labrie F; Simard J Int J Cancer; 1994 Nov; 59(3):400-7. PubMed ID: 7927949 [TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH; Mullink H; van Diest PJ; Meijer GA; Meijer CJ J Clin Pathol; 1999 Apr; 52(4):283-90. PubMed ID: 10474521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]